The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Daratumumab (DARA) in combination with carfilzomib, lenalidomide, and dexamethasone (KRd) in patients (pts) with newly diagnosed multiple myeloma (MMY1001): An open-label, phase 1b study.
 
Andrzej J. Jakubowiak
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Sanofi; Skyline Diagnostics; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Sanofi; Skyline Diagnostics; Takeda
 
Ajai Chari
Consulting or Advisory Role - Amgen; Array Biopharma; Bristol-Myers Squibb; Celgene; Janssen Oncology; Millennium; Novartis
Research Funding - Acetylon Pharmaceuticals (Inst); Array BioPharma; Biotest (Inst); Bristol-Myers Squibb (Inst); Celgene; Janssen; Millennium; Novartis; Onyx; Pharmacyclics
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Novartis; Takeda
 
Sagar Lonial
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen Oncology; Millennium; Novartis; Onyx; Sanofi
 
Brendan M. Weiss
Consulting or Advisory Role - Janssen Research & Development; Millennium
Research Funding - Janssen Research & Development; Prothena
 
Raymond L. Comenzo
Consulting or Advisory Role - Janssen; Prothena
Research Funding - Janssen; Karyopharm Therapeutics; Prothena; Takeda
Patents, Royalties, Other Intellectual Property - Not Licensed
 
Kaida Wu
Employment - Janssen
 
Nushmia Z. Khokhar
Employment - Janssen
 
Jianping Wang
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Parul Doshi
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
Patents, Royalties, Other Intellectual Property - Janssen Research & Development
 
Saad Zafar Usmani
Consulting or Advisory Role - Amgen; Celgene; Janssen Oncology
Speakers' Bureau - Amgen; Celgene; Takeda
Research Funding - Array BioPharma; Celgene; Janssen Oncology; Millennium; Onyx; Pharmacyclics; Sanofi